Jpmorgan Chase & CO Celldex Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 56,364 shares of CLDX stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,364

Previous 46,755 20.55%

Holding current value

$1.43 Million

Previous $1.96 Million 6.32%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$32.76 - $42.56 $314,790 - $408,959	9,609 Added 20.55%	56,364 $2.09 Million
Q1 2024 May 10, 2024	SELL	$35.22 - $51.88 $1.01 Million - $1.49 Million	-28,715 Reduced 38.05%	46,755 $1.96 Million
Q4 2023 Feb 12, 2024	BUY	$22.61 - $40.65 $289,249 - $520,035	12,793 Added 20.41%	75,470 $2.99 Million
Q3 2023 Nov 14, 2023	SELL	$25.45 - $37.46 $945,365 - $1.39 Million	-37,146 Reduced 37.21%	62,677 $1.72 Million
Q2 2023 Aug 11, 2023	BUY	$30.29 - $38.28 $854,480 - $1.08 Million	28,210 Added 39.39%	99,823 $3.39 Million
Q1 2023 May 18, 2023	BUY	$34.78 - $47.43 $2.02 Million - $2.76 Million	58,174 Added 432.87%	71,613 $2.58 Million
Q1 2023 May 11, 2023	SELL	$34.78 - $47.43 $1.2 Million - $1.64 Million	-34,616 Reduced 72.03%	13,439 $483,000
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $143,233 - $233,979	5,156 Added 12.02%	48,055 $2.14 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $12,553 - $20,776	553 Added 1.31%	42,899 $1.21 Million
Q2 2022 Aug 11, 2022	BUY	$20.5 - $37.33 $152,889 - $278,407	7,458 Added 21.38%	42,346 $1.14 Million
Q1 2022 May 11, 2022	SELL	$27.64 - $39.32 $2.57 Million - $3.65 Million	-92,946 Reduced 72.71%	34,888 $1.19 Million
Q4 2021 Feb 10, 2022	SELL	$35.68 - $56.27 $2.98 Million - $4.71 Million	-83,619 Reduced 39.54%	127,834 $4.94 Million
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $6.12 Million - $11.8 Million	211,453 New	211,453 $11.4 Million

Others Institutions Holding CLDX

# of Institutions

196

Shares Held

63.8M

Call Options Held

212K

Put Options Held

176K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.19B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Celldex Therapeutics, Inc. Transaction History